<VariationArchive VariationID="569363" VariationName="NM_000891.3(KCNJ2):c.1102del (p.Leu368fs)" VariationType="Deletion" Accession="VCV000569363" Version="6" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2018-10-10" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="571569" VariationID="569363">
      <GeneList>
        <Gene Symbol="KCNJ2" FullName="potassium inwardly rectifying channel subfamily J member 2" GeneID="3759" HGNC_ID="HGNC:6263" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="70169532" stop="70180044" display_start="70169532" display_stop="70180044" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="68165675" stop="68176184" display_start="68165675" display_stop="68176184" Strand="+" />
          </Location>
          <OMIM>600681</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000891.3(KCNJ2):c.1102del (p.Leu368fs)</Name>
      <CanonicalSPDI>NC_000017.11:70176139:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="70176140" stop="70176140" display_start="70176140" display_stop="70176140" variantLength="1" positionVCF="70176139" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="68172281" stop="68172281" display_start="68172281" display_stop="68172281" variantLength="1" positionVCF="68172280" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>L368fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000891.2" sequenceAccession="NM_000891" sequenceVersion="2" change="c.1102delC">
            <Expression>NM_000891.2:c.1102delC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.68172282del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.68172282del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.70176141del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.70176141del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008798.1" sequenceAccession="NG_008798" sequenceVersion="1" change="g.11607del">
            <Expression>NG_008798.1:g.11607del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000891.3" sequenceAccession="NM_000891" sequenceVersion="3" change="c.1102del" MANESelect="true">
            <Expression>NM_000891.3:c.1102del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000882.1" sequenceAccession="NP_000882" sequenceVersion="1" change="p.Leu368fs">
            <Expression>NP_000882.1:p.Leu368fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_328" sequenceAccession="LRG_328">
            <Expression>LRG_328:g.11607del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1567823248" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000891.3(KCNJ2):c.1102del (p.Leu368fs) AND multiple conditions" Accession="RCV000689975" Version="6">
        <ClassifiedConditionList TraitSetID="9142">
          <ClassifiedCondition DB="MedGen" ID="C1563715">Andersen Tawil syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1865018">Short QT syndrome type 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-05-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-05-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-10-10" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21493816</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9142" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="244" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Andersen Tawil syndrome</ElementValue>
                <XRef ID="Andersen+Tawil+Syndrome/431" DB="Genetic Alliance" />
                <XRef ID="422348008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Andersen cardiodysrhythmic periodic paralysis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Long QT syndrome 7</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Periodic paralysis, potassium-sensitive cardiodysrhythmic type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Andersen Syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ATS</ElementValue>
                <XRef Type="MIM" ID="170390" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">LQT7</ElementValue>
                <XRef Type="MIM" ID="170390" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Andersen-Tawil syndrome (ATS) is characterized by a triad of: episodic flaccid muscle weakness (i.e., periodic paralysis); ventricular arrhythmias and prolonged QT interval; and anomalies including low-set ears, widely spaced eyes, small mandible, fifth-digit clinodactyly, syndactyly, short stature, and scoliosis. Affected individuals present in the first or second decade with either cardiac symptoms (palpitations and/or syncope) or weakness that occurs spontaneously following prolonged rest or following rest after exertion. Mild permanent weakness is common. Mild learning difficulties and a distinct neurocognitive phenotype (i.e., deficits in executive function and abstract reasoning) have been described.</Attribute>
                <XRef ID="NBK1264" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9453" />
                <XRef ID="9453" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301441</ID>
                <ID Source="BookShelf">NBK1264</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="37553" DB="Orphanet" />
              <XRef ID="C1563715" DB="MedGen" />
              <XRef ID="MONDO:0008222" DB="MONDO" />
              <XRef Type="MIM" ID="170390" DB="OMIM" />
            </Trait>
            <Trait ID="3722" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Short QT syndrome type 3</ElementValue>
                <XRef ID="MONDO:0012314" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SQT3</ElementValue>
                <XRef Type="MIM" ID="609622" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18635" />
                <XRef ID="18635" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <XRef ID="51083" DB="Orphanet" />
              <XRef ID="C1865018" DB="MedGen" />
              <XRef ID="MONDO:0012314" DB="MONDO" />
              <XRef Type="MIM" ID="609622" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1589868" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="4325605|MedGen:C1865018;C1563715" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000817648" DateUpdated="2024-02-28" DateCreated="2018-10-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-05-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21493816</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. A different truncation (p.Ser369*) that lies downstream of this variant has been determined to be pathogenic (PMID: 21493816). This suggests that deletion of this region of the KCNJ2 protein is causative of disease. This variant has not been reported in the literature in individuals with KCNJ2-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the KCNJ2 gene (p.Leu368Serfs*39). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 60 amino acids of the KCNJ2 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNJ2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.68172281del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1865018" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1563715" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB4474525</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1589868" TraitType="Disease" MappingType="XRef" MappingValue="C1865018" MappingRef="MedGen">
        <MedGen CUI="C1865018" Name="Short QT syndrome type 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1589868" TraitType="Disease" MappingType="XRef" MappingValue="C1563715" MappingRef="MedGen">
        <MedGen CUI="C1563715" Name="Andersen Tawil syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

